Menu Search
Equities

Japan Hospice Holdings Inc

7061:TYO

Japan Hospice Holdings Inc

Actions
Health CareHealth Care Providers
  • Price (JPY)1,351.00
  • Today's Change-10.00 / -0.73%
  • Shares traded83.70k
  • 1 Year change-44.10%
  • Beta1.3722
Data delayed at least 20 minutes, as of Nov 26 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Japan Hospice Holdings Inc grew revenues 25.05% from 7.89bn to 9.87bn while net income improved 49.95% from 454.73m to 681.88m.
Gross margin16.35%
Net profit margin4.86%
Operating margin10.04%
Return on assets3.51%
Return on equity19.38%
Return on investment4.15%
More ▼

Cash flow in JPYView more

In 2023, Japan Hospice Holdings Inc increased its cash reserves by 24.85%, or 374.98m. The company earned 1.13bn from its operations for a Cash Flow Margin of 11.45%. In addition the company generated 256.45m cash from financing while 1.01bn was spent on investing.
Cash flow per share112.98
Price/Cash flow per share11.90
Book value per share392.09
Tangible book value per share343.77
More ▼

Balance sheet in JPYView more

Japan Hospice Holdings Inc has a Debt to Total Capital ratio of 80.16%, a lower figure than the previous year's 366.91%.
Current ratio1.26
Quick ratio--
Total debt/total equity4.04
Total debt/total capital0.8016
More ▼

Growth rates in JPY

Year on year, growth in earnings per share excluding extraordinary items increased 49.74%. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
EPS growth(5 years)33.23
EPS (TTM) vs
TTM 1 year ago		-27.83
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.